mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
0.42 |
0.003 |